2/7/26 S12 E1375: DR. TAHMID RAHMAN - TREATMENT FOR RARE LIPID DISEASE

2/7/26 S12 E1375: DR. TAHMID RAHMAN - TREATMENT FOR RARE LIPID DISEASE

Curious about how others navigate their sobriety journey? This episode of American Medicine Today dives into the groundbreaking developments in treating a rare lipid disorder known as familial chylomicronemia syndrome (FCS). Dr. Tahmid Rahman, co-director at the Stony Brook Heart Institute, shares his expertise on FCS, a genetic condition leading to dangerously high triglyceride levels and the risk of acute pancreatitis.

He explains the challenges in diagnosing this rare disorder and the limitations of traditional treatments, which often leave patients with unmanaged symptoms. In a breakthrough for those affected, Dr. Rahman discusses the new RNA interference therapy, a cutting-edge treatment targeting the APOC3 protein, responsible for regulating triglyceride breakdown. This innovative approach has shown promising results, with significant reductions in triglyceride levels for patients.

The episode also touches on the broader landscape of rare lipid disorders, including familial hyperlipidemia and other genetic conditions affecting cholesterol levels. Dr. Rahman emphasises the importance of lifestyle changes alongside medical treatments and addresses common myths about statins and their alleged link to dementia. Listeners will gain valuable insights into the latest advancements in medical science, offering hope for those battling these challenging conditions.

Whether you're directly affected or simply interested in medical innovation, this episode provides a fascinating look into how modern medicine is tackling rare diseases. What can we learn from the experts about managing rare genetic disorders? Tune in to discover more about these life-changing treatments and their potential impact.